Ann Cardiovasc Surg | Volume 4, Issue 1 | Case Report | Open Access

COVID-19 Associated Left Ventricular Assist Device Pump Thrombosis with Hemolysis and Pigment Nephropathy: Case Report

Louis Samuels1*, Alexandra Tuluca2, Marissa Samuels1, Timothy Robbins2, Rafael Bonita2 and Benham Bozorgnia2

1Department of Cardiac Surgery, Thomas Jefferson University, USA 2Department of Cardiac Surgery, Albert Einstein Medical Center, USA

^*Correspondance to: Louis Samuels 

Abstract

COVID-19 infection has manifested itself in several ways, most notably respiratory failure. However, this virus has also been shown to induce a hypercoagulable state resulting in myocardial infarction, pulmonary embolism, and stroke. We present a unique case in which a Left Ventricular Assist Device (LVAD) patient became infected with COVID-19 resulting in thrombosis of the LVAD and kidney dysfunction from the hemolysis and pigment nephropathy. Aggressive treatment with lytic and anticoagulant therapy resolved the pump thrombosis and the associated acute kidney injury associated with it.

Keywords:

Left ventricular assist device; COVID-19; Pump thrombosis; Hemolysis; Pigment nephropathy

Citation:

Samuels L, Tuluca A, Samuels M, Robbins T, Bonita R, Bozorgnia B. COVID-19 Associated Left Ventricular Assist Device Pump Thrombosis with Hemolysis and Pigment Nephropathy: Case Report. Ann Cardiovasc Surg. 2021;4(1):1027..